UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
$919M |
| 2 |
Snowflake
SNOW
|
$576M |
| 3 |
Sea Limited
SE
|
$521M |
| 4 |
Procter & Gamble
PG
|
$485M |
| 5 |
Snap
SNAP
|
$412M |
Top Sells
| 1 |
Infosys
INFY
|
$428M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
$350M |
| 3 |
Lowe's Companies
LOW
|
$219M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
$183M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$183M |
Sector Composition
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
ImmunityBio
IBRX
$2.27B
| $420K | ﹤0.01% |
43,139
+17,217
| +66% | +$168K |
|
2502
TruBridge
TBRG
$300M
| $420K | ﹤0.01% |
11,849
-1,966
| -14% | -$69.7K |
|
|
BCEL
2503
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $419K | ﹤0.01% |
67,312
+18,418
| +38% | +$115K |
|
2504
Mersana Therapeutics
MRSN
$34M
| $409K | ﹤0.01% |
1,737
| – | – |
|
2505
Barrett Business Services
BBSI
$1.24B
| $408K | ﹤0.01% |
21,400
+4,000
| +23% | +$76.3K |
|
2506
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $404K | ﹤0.01% |
+35,490
| New | +$404K |
|
2507
Spruce Power Holding Corp
SPRU
$27.3M
| $404K | ﹤0.01% |
8,191
| – | – |
|
2508
Lexicon Pharmaceuticals
LXRX
$396M
| $403K | ﹤0.01% |
83,874
+7,499
| +10% | +$36.1K |
|
2509
Esperion Therapeutics
ESPR
$540M
| $403K | ﹤0.01% |
33,476
| – | – |
|
2510
Hims & Hers Health
HIMS
$10.9B
| $403K | ﹤0.01% |
53,420
+4,159
| +8% | +$31.4K |
|
|
TCS
2511
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $402K | ﹤0.01% |
2,817
+534
| +23% | +$76.2K |
|
|
ABST
2512
DELISTED
Absolute Software Corporation Common Stock
ABST
| $402K | ﹤0.01% |
36,600
| – | – |
|
2513
United Microelectronic
UMC
$17.1B
| $400K | ﹤0.01% |
35,000
-3,700
| -10% | -$42.3K |
|
|
GAN
2514
DELISTED
GAN Ltd
GAN
| $399K | ﹤0.01% |
26,805
+5,405
| +25% | +$80.4K |
|
|
ORLA
2515
Orla Mining
ORLA
$3.82B
| $397K | ﹤0.01% |
120,400
| – | – |
|
2516
Citi Trends
CTRN
$313M
| $397K | ﹤0.01% |
5,435
+2,232
| +70% | +$163K |
|
|
DX
2517
Dynex Capital
DX
$1.68B
| $396K | ﹤0.01% |
22,932
-11,838
| -34% | -$205K |
|
2518
iShares MSCI Turkey ETF
TUR
$165M
| $395K | ﹤0.01% |
18,601
-5,363
| -22% | -$114K |
|
2519
Village Farms International
VFF
$301M
| $394K | ﹤0.01% |
47,220
+3,920
| +9% | +$32.7K |
|
|
SDC
2520
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $391K | ﹤0.01% |
73,493
+7,445
| +11% | +$39.6K |
|
2521
El Pollo Loco
LOCO
$314M
| $390K | ﹤0.01% |
23,101
+2,720
| +13% | +$46K |
|
2522
Sapiens International
SPNS
$2.4B
| $380K | ﹤0.01% |
13,207
| – | – |
|
2523
Geron
GERN
$893M
| $379K | ﹤0.01% |
276,819
| – | – |
|
2524
McEwen Inc.
MUX
$734M
| $378K | ﹤0.01% |
36,377
| – | – |
|
2525
Adverum Biotechnologies
ADVM
$73.9M
| $378K | ﹤0.01% |
17,398
+3,611
| +26% | +$78.4K |
|